Controls of Nuclear Factor-Kappa B Signaling Activity by 5’-AMP-Activated Protein Kinase Activation With Examples in Human Bladder Cancer Cells

키워드

참고문헌 (67)

1. Pahl HL, "Activators and target genes of Rel", NF-kappaB transcription factors, 1999, pp.18, 6853~6866
2. Karin M, "NF-kappaB in cancer: from innocent bystander to major culprit", Nat Rev Cancer, 2, pp.301~310 (2002)
3. Karin M, "NF-kappaB at the crossroads of life and death", Nat Immunol, 3, pp.221~227 (2002)
4. Hayden MS, "NF-kappaB and the immune response", Oncogene, 25, pp.6758~6780 (2006)
5. Henkel T, "Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B", Nature, 365, pp.182~185 (1993)
6. Spencer E, "Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb", beta-TrCP, 1999, pp.13, 284~294
7. Jung YJ, "IL-1beta-mediated upregulation of HIF-1alpha via an NFkappaB", COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis, 2003, pp.17, 2115~2117
8. Hara Y, "Hypoxia-altered signaling pathways of toll-like receptor 4 (TLR4) in human corneal epithelial cells", Mol Vis, 15, pp.2515~2520 (2009)
9. Bruning U, "NFκB and HIF display synergistic behaviour during hypoxic inflammation", Cell Mol Life Sci, 69, pp.1319~1329 (2012)
10. Lei Q, "Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1αsignaling pathways", Int J Mol Med, 34, pp.1629~1639 (2014)
11. Arenzana-Seisdedos F, "Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B", Mol Cell Biol, 15, pp.2689~2696 (1995)
12. Zhong H, "The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism", Cell, 89, pp.413~424 (1997)
13. Wang D, "Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA", p65 on serine 529, 1998, pp.273, 29411~29416
14. Chen LF, "Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB", EMBO J, 21, pp.6539~6548 (2002)
15. Zhong H, "Phosphorylation of NF-kappa B p65by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP", p300, 1998, pp.1, 661~671
16. Duran A, "Essential role of RelA Ser311phosphorylation by zetaPKC in NF-kappaB transcriptional activation", EMBO J, 22, pp.3910~3918 (2003)
17. Anrather J, "cis-acting, element-specific transcriptional activity of differentially phosphorylated nuclear factor-kappa B", J Biol Chem, 280, pp.244~252 (2005)
18. Sakurai H, "IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain", J Biol Chem, 274, pp.30353~30356 (1999)
19. Haller D, "IKK beta and phosphatidylinositol 3-kinase", Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines, 2002, pp.277, 38168~38178
20. Mattioli I, "Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import", J Immunol, 172, pp.6336~6344 (2004)
21. Hochrainer K, "Hypo-phosphorylation leads to nuclear retention of NF-kappaB p65 due to impaired IkappaBalpha gene synthesis", FEBS Lett, 581, pp.5493~5499 (2007)
22. Pejanovic N, "Regulation of nuclear factor κB (NF-κB) transcriptional activity via p65 acetylation by the chaperonin containing TCP1 (CCT)", PLoS One, 7, pp.e42020~ (2012)
23. Hochrainer K, "Site-specific phosphorylation of the p65 protein subunit mediates selective gene expression by differential NF-κB and RNA polymerase II promoter recruitment", J Biol Chem, 288, pp.285~293 (2013)
24. Chen JJ, "Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias", Blood, 109, pp.2693~2699 (2007)
25. Chen LF, "Shaping the nuclear action of NF-kappaB", Nat Rev Mol Cell Biol, 5, pp.392~401 (2004)
26. Hawley SA, "Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase", J Biol Chem, 271, pp.27879~27887 (1996)
27. Hardie DG, "The AMP-activated protein kinase--fuel gauge of the mammalian cell?", Eur J Biochem, 246, pp.259~273 (1997)
28. Hardie DG, "Management of cellular energy by the AMP-activated protein kinase system", FEBS Lett, 546, pp.113~120 (2003)
29. Woods A, "Ca2+", calmodulin-dependent protein kinase kinasebeta acts upstream of AMP-activated protein kinase in mammalian cells, 2005, pp.2, 21~33
30. Xie M, "A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1", AMP-activated protein kinase energy-sensor pathway, 2006, pp.103, 17378~17383
31. Sanders MJ, "Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade", Biochem J, 403, pp.139~148 (2007)
32. Herrero-Martín G, "TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells", EMBO J, 28, pp.677~685 (2009)
33. Zhao X, "Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury", Am J Physiol Lung Cell Mol Physiol, 295, pp.L497~L504 (2008)
34. Andreasen AS, "Type 2diabetes is associated with altered NF-κB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS", PLoS One, 6, pp.e23999~ (2011)
35. Barroso E, "The peroxisome proliferator-activated receptor β", δ (PPARβ, Biochem Pharmacol, pp.2011, 81[DOI]
36. Green CJ, "Counter-modulation of fatty acid-induced pro-inflammatory nuclear factor κB signalling in rat skeletal muscle cells by AMP-activated protein kinase", Biochem J, 435, pp.463~474 (2011)
37. Green CJ, "Elevated NF-κB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase", Diabetes, 60, pp.2810~2819 (2011)
38. Kubota S, "Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation", Invest Ophthalmol Vis Sci, 52, pp.9142~9148 (2011)
39. Zhang Y, "AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300", Arterioscler Thromb Vasc Biol, 31, pp.2897~2908 (2011)
40. Ji G, "Genistein suppresses LPS-induced inflammatory response through inhibiting NF-κB following AMP kinase activation in RAW 264.7 macrophages", PLoS One, 7, pp.e53101~ (2012)
41. Kim HS, "Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression", Biochem Pharmacol, 83, pp.385~394 (2012)
42. Moiseeva O, "Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK", NF-κB activation, 2013, pp.12, 489~498
43. Jiménez-Flores LM, "A PPARγ, NF-κB and AMPK-dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db", db mice liver, 2014, pp.19, 8289~8302
44. Li J, "Genistein suppresses tumor necrosis factor α-induced inflammation via modulating reactive oxygen species", Akt, Drug Des Devel Ther, pp.2014, 8[DOI]
45. Mo C, "The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice", Antioxid Redox Signal, 20, pp.574~588 (2014)
46. Nalli AD, "Hypercontractility of intestinal longitudinal smooth muscle induced by cytokines is mediated by the nuclear factor-κB", AMP-activated kinase, J Pharmacol Exp Ther, pp.2014, 350[DOI]
47. Tsai KL, "Aspirin attenuates vinorelbine-induced endothelial inflammation via modulating SIRT1", AMPK axis, 2014, pp.88, 189~200
48. Huang BP, "AMPK activation inhibits expression of proinflammatory mediators through downregulation of PI3K", p38 MAPK and NF-κB signaling in murine macrophages, 2015, pp.34, 133~141
49. Giri S, "5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase", J Neurosci, 24, pp.479~487 (2004)
50. Jin Q, "Differential regulation of phosphatidylinositol 3-kinase", Akt, mitogen-activated protein kinase, and AMP-activated protein kinase pathways during menadione-induced oxidative stress in the kidney of young and old rats, 2004, pp.315, 555~561
51. Levine YC, "Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK->Rac1->Akt->endothelial nitric-oxide synthase pathway", J Biol Chem, 282, pp.20351~20364 (2007)
52. Kuo CL, "Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase", J Cell Biochem, 103, pp.931~940 (2008)
53. Centeno-Baez C, "Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1", Am J Physiol Endocrinol Metab, 301, pp.E922~E930 (2011)
54. Wang L, "Lipopolysaccharides reduce adipogenesis in 3T3-L1 adipocytes through activation of NF-κB pathway and downregulation of AMPK expression", Cardiovasc Toxicol, 13, pp.338~346 (2013)
55. Jhun BS, "5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharideinduced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase", Akt activation in RAW 264.7 murine macrophages, 2004, pp.318, 372~380
56. Göransson O, "Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase", J Biol Chem, 282, pp.32549~32560 (2007)
57. Kim HS, "Quercetin enhances hypoxia-mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer", Apoptosis, 17, pp.938~949 (2012)
58. Hawley SA, "The ancient drug salicylate directly activates AMPactivated protein kinase", Science, 336, pp.918~922 (2012)
59. Sag D, "Adenosine 5’-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype", J Immunol, 181, pp.8633~8641 (2008)
60. Tadie JM, "Toll-like receptor 4 engagement inhibits adenosine 5’-monophosphate-activated protein kinase activation through a high mobility group box 1 protein-dependent mechanism", Mol Med, 18, pp.659~668 (2012)
61. Prasad R, "5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelialmonocyte interaction", J Neurosci Res, 84, pp.614~625 (2006)
62. Chuntao Yang, "Oxidative Stress Mediates Chemical Hypoxia-Induced Injury and Inflammation by Activating NF-κb-COX-2 Pathway in HaCaT Cells", Molecules and Cells, 31(6), pp.531~538 (2011), 한국분자세포생물학회
63. Yang C, "Hydrogen sulfide protects against chemical hypoxia-induced cytotoxicity and inflammation in HaCaT cells through inhibition of ROS", NF-κB, PLoS One, pp.2011, 6[DOI]
64. Luo H, "Role of TLR4", NF-κB in damage to intestinal mucosa barrier function and bacterial translocation in rats exposed to hypoxia, 2012, pp.7, e46291~
65. Tewari R, "Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma", J Mol Med (Berl), 90, pp.67~80 (2012)
66. Laderoute KR, "5’-AMP-activated protein kinase (AMPK) is induced by lowoxygen and glucose deprivation conditions found in solid-tumor microenvironments", Mol Cell Biol, 26, pp.5336~5347 (2006)
67. Miller EJ, "Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart", Nature, 451, pp.578~582 (2008)

관련 논문AI추천